California Doctor’s $35 Million Hospice Billing Case: Medical Billing Practices under Scrutiny

In a case that highlights the complexities of hospice care funding and medical billing, a California physician’s activity regarding hospice services drew intense scrutiny in 2025. Records show that the physician billed Medicare for more than $35 million in hospice care services during that year, prompting federal authorities to revoke her Medicare billing privileges. The episode has sparked questions about oversight, patient safety, and the economic dynamics of end-of-life care across a diverse regional landscape.

Historical context: hospice care in the U.S. and California Hospice care, established to provide comfort and quality of life for patients with limited life expectancy, has grown into a substantial segment of the U.S. health care system. The program emphasizes multidisciplinary care—medical, emotional, and social support—often delivered in the patient’s home or in dedicated facilities. In the last two decades, Medicare and Medicaid have become major payers for hospice services, with reimbursement tied to patient eligibility, physician involvement, and the use of certified hospice providers.

California’s hospice sector reflects the state’s size and diversity. Large urban centers, suburban communities, and rural regions each present distinct logistical and regulatory challenges. The state hosts a mix of hospital-affiliated hospice programs, standalone hospices, and nursing-home-based palliative care services. This mosaic has driven robust demand for hospice care, as families seek compassionate end-of-life options that align with personal, cultural, and financial considerations.

What happened in 2025: billing activity and licensing actions According to Centers for Medicare and Medicaid Services (CMS) data, the physician billed Medicare for more than $35 million for hospice care services during 2025. The physician held roles across a broad network of hospice facilities in California, including positions as medical director or attending physician. The total footprint extended to 63 hospice facilities, and the physician’s National Provider Identifier (NPI) was associated with 1,662 unique patients and more than 6,000 claims.

CMS subsequently revoked the physician’s Medicare billing privileges after reviewing the observed billing activity. CMS Administrator Dr. Mehmet Oz characterized the case as a stark reminder of the obligation to uphold medical standards and the principle of “do no harm.” He described the activity as “devastating damage disguised as help,” signaling a strong emphasis on provider accountability in Medicare-funded hospice services. Notably, the physician has not been charged with criminal wrongdoing in the public statements released by CMS.

The broader claim history stretches back to 2018, with the NPI linked to more than 31,000 claims across 130 hospice agencies, totaling more than $173 million through September 2025. The sheer scale of activity raised alarms within Medicare’s audit and enforcement programs and prompted a closer look at licensing, credentialing, and the integrity of hospice billing practices.

Divergent narratives from the physician The physician has presented a counter-narrative focused on alleged identity misuse and fraud by third parties. She asserts that her NPI and identity were compromised by HospiceMD, a cloud-based electronic medical records platform used by hospice agencies. According to the physician, fraudulent agencies appeared under her name without her knowledge. She has stated that she now works with a narrow set of seven hospice agencies, performing “problem solving” duties for a monthly salary, and that a significant portion of patient death events attributed to her occurred in the context of this alleged fraud.

The physician’s accounts include claims of ongoing contact with patients about potential fraud indicators and a reported daily death rate that she contends is inconsistent with the numbers reflected in official records. In response, CMS indicated it had no record of fraud involving the physician’s identifier. Billing records were cited as not supporting the higher death-rate claims associated with the patient roster. The discrepancy between claimed patient outcomes and CMS records has become a focal point of the public discussion surrounding this case.

Regulatory and enforcement responses CMS’s action to revoke Medicare billing privileges is a significant regulatory step designed to protect beneficiaries and the integrity of the Medicare program. The decision underscores the importance of accurate patient attribution, valid provider authentication, and transparent billing practices within hospice care. The case has prompted discussions among policymakers, regulatory bodies, and industry stakeholders about safeguards against fraudulent billing, the reliability of third-party software platforms, and the verification processes for provider identities across multiple facilities.

Regional implications: how other markets compare California’s hospice landscape—already extensive and varied—provides a useful backdrop for assessing the broader national context. Several other states with large aging populations and extensive hospice networks have implemented parallel measures to curb improper billing, including enhanced credentialing, cross-facility audits, and more stringent monitoring of physician involvement in care delivery. In markets with mature hospice ecosystems, regulators emphasize standardized documentation, patient consent processes, and independent medical review to ensure that hospice services align with established medical criteria.

Economy and health-care delivery impact Hospice services represent a meaningful portion of health care expenditures, reflecting both end-of-life care preferences and cost considerations. While hospice care is often cost-effective relative to certain hospital-based end-of-life services, the integrity of billing practices determines the value offered to patients and taxpayers. Inaccurate or fraudulent billing can drive up costs, distort resource allocation, and erode trust in essential services.

For providers and payers, the case highlights several economic considerations:

• Verification of provider identity across multiple facilities to prevent misattribution and fraud.
• The role of third-party platforms in credential management and data integrity.
• The balance between accessible palliative care and stringent oversight to minimize waste and abuse.
• The potential impact on patient access if networks alarmingly tighten due to over-caution or license suspensions.

Public reaction and patient experience End-of-life care resonates deeply with families and communities. When billing practices come under scrutiny, it can evoke mixed reactions: concern about the safety and quality of care for vulnerable patients, questions about systemic safeguards, and calls for clarity in how hospice services are coordinated and billed. In California, where many families navigate complexities surrounding caregiving, housing, and insurance, such cases can amplify public attention on the transparency and accountability of providers and the technology platforms that support clinical operations.

Key regional comparisons

• West Coast: California’s regulatory framework emphasizes rigorous oversight of hospice providers, with a track record of pursuing license suspensions when compliance lapses are identified. The case aligns with ongoing efforts to tighten credentialing and ensure proper patient attribution.
• Pacific Northwest and Southwest: In neighboring regions with similarly large elder-care populations, authorities have pursued related enforcement actions, focusing on the intersection of telehealth, cloud-based records, and multi-facility practice patterns to prevent misrepresentation.
• National landscape: Across the United States, federal and state agencies increasingly scrutinize hospice billing to deter improper compensation, while preserving access to compassionate care that aligns with patient needs and clinical indications.

Clinical and ethical considerations Hospice care centers on patient comfort, dignity, and informed decision-making. Clinicians are expected to adhere to evidence-based practices, ensure accurate documentation, and coordinate with families and other care teams. When billing narratives shift toward profit-centric patterns or when there is ambiguity about patient eligibility, the ethical foundation of care comes into question. The delicate balance between administrative efficiency and patient-centered care is a constant challenge in palliative medicine, particularly in high-volume networks where thousands of claims may be processed across multiple facilities.

What this means for patients and families For patients and families navigating hospice care, clear communication about eligibility, service scope, and expected outcomes remains essential. Regulatory actions that improve transparency—such as standardized patient attribution, auditable billing trails, and robust credentialing—can help families understand what services are being provided and why they are billed in a particular way. As regulators continue to refine oversight mechanisms, patients rely on hospitals, hospices, and clinicians to maintain the highest standards of care and accountability.

Future considerations and possible developments

• Strengthened identity verification: Expect ongoing enhancements in how provider identities are authenticated across facilities and platforms to prevent impersonation and billing fraud.
• Audit and analytics: Regulators may expand data-driven audits, using machine-learning models to flag unusual patterns in hospice claims, patient death rates, and provider involvement across networks.
• Platform accountability: Vendors that supply cloud-based medical records will face greater scrutiny to ensure they do not enable fraudulent activity and to provide clearer traceability of user actions.
• Patient-centered reforms: Policymakers could push for reforms that reinforce patient choice, ensure clarity around hospice eligibility criteria, and support families in understanding the care continuum.

Conclusion The 2025 case involving a California physician’s hospice billing activity underscores the ongoing tension between the essential mission of hospice care and the safeguards required to maintain financial integrity in a complex health-care system. While the public emphasis centers on regulatory actions and licensing decisions, the broader narrative highlights the need for robust verification, transparent documentation, and accountable care delivery that keeps patient welfare at the forefront. As the industry learns from this episode, the path forward points toward strengthened systems that protect patients, support legitimate providers, and sustain the trusted, compassionate ethos at the heart of hospice care.